Neostigmine Methylsulfate
Product Images NDC 25021-610

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 25021-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neo0d 0002 01

Chemical structure of Neostigmine Methylsulfate depicting its molecular components including nitrogen, methyl groups, sulfate, and aromatic ring elements.*

FDA Label Image

Neo0d 0002 02

Neostigmine Methylsulfate Injection, USP, 5 mg per 10 mL (0.5 mg per mL) multiple dose vial label. The sterile, nonpyrogenic injectable is for intravenous use. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, and made in India. The label includes usage details, sterility information, and storage instructions.*

FDA Label Image

Neo0d 0002 03

Neostigmine Methylsulfate Injection, USP 10 mg per 10 mL (1 mg per mL) vial label by Sagent Pharmaceuticals. The label indicates it is for intravenous use, a 10 mL multiple dose vial, sterile and nonpyrogenic, with additional details on contents and preservative. Manufactured for Sagent Pharmaceuticals, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.